# Effects of Nitric Oxide for Inhalation in Myocardial Infarction Size

> **NCT01398384** · PHASE2 · COMPLETED · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 250 (actual)

## Conditions studied

- Acute Myocardial Infarction

## Interventions

- **DRUG:** Nitric Oxide
- **DRUG:** MI size at 48-72 hours

## Key facts

- **NCT ID:** NCT01398384
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2014-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01398384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01398384, "Effects of Nitric Oxide for Inhalation in Myocardial Infarction Size". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01398384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*